SEC Form D · filed June 3, 2020
Palvella Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
Elaine H. Heron · Wayne, PADirectorGeorge H. Jenkins · Wayne, PADirectorTodd H. Davis · Wayne, PADirectorKathleen S. Mcgowan · Wayne, PAExecScott H. Morenstein · Wayne, PADirectorWesley H. Kaupinen · Wayne, PAExec · DirectorKathleen S. Goin · Wayne, PAExecJohn H. Doux · Wayne, PADirectorCory H. Freedland · Wayne, PADirectorKerrie H. Brady · Boston, MADirectorMatt Ross · New York, NYExecWilliam H. Koster · Boston, MADirectorAntonios T. Valamontes · Largo, FLExec · DirectorTom Broussard · Boston, MADirectorBrandon Alexander · San Carlos, CADirectorDavid S. Edwards · Boston, MAExecEric D. Chin · San Carlos, CADirectorBraham A. Shroot, Ph.D · Wayne, PAExecMichael Konnert · VANCOUVER, British Columbia, CanadaExec · DirectorKimberley Yates · Redwood City, CADirectorAlan Hartman · Redwood City, CADirectorMichael Kaplan · Redwood City, CADirectorDavid Krane · Mountain View, CAExecWilliam B. Bissett · Charlotte, NCExecShawn Anderson · Idaho Falls, IDDirectorKristoffer E. Bertagnolli · Idaho Falls, IDDirectorCory H. Freedland · Wayne, PADirectorBraham A. Shroot, Ph.D · Wayne, PAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗